As the weather turns colder, many people notice their breathing feels a little heavier and chest discomfort rises. For people ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

A Wigan mum-of-two is urging people to attend their NHS lung cancer screening after it saved her life. Gillian Glynn, 60, ...

Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in ...

J&J has hypothesized that subcutaneous absorption of the drug may potentially enhance immune-mediated anticancer activity.

With lung cancer claiming too many lives, the singer-songwriter wants mob to know about the new National Lung Cancer ...

The cover feature on correcting hospice misconceptions in this seasonal issue of CURE by Senior Editor Alex Biese elegantly ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

The green light for Rybrevant Faspro – which combines amivantamab with hyaluronidase – means that the drug is the first ...

Genetic alterations lie at the heart of cancer development, but scientists may have been overlooking a powerful driver of these changes—the everyday nutrients that feed our cells.

The FDA approves a new subcutaneous formulation of amivantamab, enhancing treatment for advanced lung cancer with reduced administration time and improved safety.

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been randomized in the RASolute ...